Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand

被引:9
作者
Jaksuwan, Risara [1 ]
Tharavichikul, Prasit [2 ]
Patumanond, Jayanton [3 ]
Chuchottaworn, Charoen [4 ]
Chanwong, Sakarin [5 ]
Smithtikarn, Saijai [6 ]
Settakorn, Jongkolnee [7 ]
机构
[1] Chiang Mai Univ, Fac Med, Clin Epidemiol Unit, Chiang Mai, Thailand
[2] Chiang Mai Univ, Dept Microbiol, Fac Med, Chiang Mai, Thailand
[3] Thammasat Univ, Div Clin Epidemiol, Fac Med, Pathum Thani, Thailand
[4] Chest Dis Inst, Div Resp Med, Nonthaburi, Thailand
[5] Off Dis Prevent & Control Reg 10, Chiang Mai, Thailand
[6] Minist Publ Hlth, Dept Dis Control, Bureau TB, Bangkok, Thailand
[7] Chiang Mai Univ, Dept Pathol, Fac Med, Chiang Mai, Thailand
关键词
tuberculosis; drug resistance; MDR-TB; XDR-TB; genotype; mutation; MYCOBACTERIUM-TUBERCULOSIS; ISONIAZID RESISTANCE; PHENOTYPIC CHARACTERIZATION; RIFAMPICIN-RESISTANT; MUTATIONS; DIAGNOSIS; GENE; TRANSMISSION; MECHANISMS; STRAINS;
D O I
10.2147/IDR.S130203
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Multidrug/extensively drug-resistant tuberculosis (M/XDR-TB) is a major public health problem, and early detection is important for preventing its spread. This study aimed to demonstrate the distribution of genetic site mutation associated with drug resistance in M/XDR-TB in the northern Thai population. Methods: Thirty-four clinical MTB isolates from M/XDR-TB patients in the upper northern region of Thailand, who had been identified for drug susceptibility using the indirect agar proportion method from 2005 to 2012, were examined for genetic site mutations of katG, inhA, and ahpC for isoniazid (INH) drug resistance and rpoB for rifampicin (RIF) drug resistance. The variables included the baseline characteristics of the resistant gene, genetic site mutations, and drug susceptibility test results. Results: All 34 isolates resisted both INH and RIF. Thirty-two isolates (94.1%) showed a mutation of at least 1 codon for katG, inhA, and ahpC genes. Twenty-eight isolates (82.4%) had a mutation of at least 1 codon of rpoB gene. The katG, inhA, ahpC, and rpoB mutations were detected in 20 (58.7%), 27 (79.4%), 13 (38.2%), and 28 (82.3%) of 34 isolates. The 3 most common mutation codons were katG 315 (11/34, 35.3%), inhA 14 (11/34, 32.4%), and inhA 114 (11/34, 32.4%). For this population, the best genetic mutation test panels for INH resistance included 8 codons (katG 310, katG 340, katG 343, inhA 14, inhA 84, inhA 86, inhA 114, and ahpC 75), and for RIF resistance included 6 codons (rpoB 445, rpoB 450, rpoB 464, rpoB 490, rpoB 507, and rpoB 508) with a sensitivity of 94.1% and 82.4%, respectively. Conclusion: The genetic mutation sites for drug resistance in M/XDR-TB are quite variable. The distribution of these mutations in a certain population must be studied before developing the specific mutation test panels for each area. The results of this study can be applied for further molecular M/XDR-TB diagnosis in the upper northern region of Thailand.
引用
收藏
页码:167 / 174
页数:8
相关论文
共 40 条
[1]   Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation [J].
Afanas'ev, Maxim V. ;
Ikryannikova, Larisa N. ;
Il'ina, Elena N. ;
Sidorenko, Sergey V. ;
Kuz'min, Aleksey V. ;
Larionova, Elena E. ;
Smirnova, Tat'yana G. ;
Chernousova, Larisa N. ;
Kamaev, Eugeny Yu ;
Skorniakov, Sergey N. ;
Kinsht, Vladimir N. ;
Cherednichenko, Andrey G. ;
Govorun, Vadim M. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (06) :1057-1064
[2]   Current status and future trends in the diagnosis and treatment of drug-susceptible and multidrug-resistant tuberculosis [J].
Ahmad, Suhail ;
Mokaddas, Eiman .
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2014, 7 (02) :75-91
[3]   Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs [J].
Almeida Da Silva, Pedro Eduardo ;
Palomino, Juan Carlos .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (07) :1417-1430
[4]   Impact of isoniazid resistance on virulence of global and south Indian clinical isolates of Mycobacterium tuberculosis [J].
Ameeruddin, Nusrath Unissa ;
Elizabeth, Hanna Luke .
TUBERCULOSIS, 2014, 94 (06) :557-563
[5]  
[Anonymous], GUID PROGR MAN DRUG
[6]   Phenotypic and Genotypic Analysis of Anti-Tuberculosis Drug Resistance in Mycobacterium tuberculosis Isolates in Myanmar [J].
Aung, Wah Wah ;
Ei, Phyu Win ;
Nyunt, Wint Wint ;
Swe, Thyn Lei ;
Lwin, Thandar ;
Htwe, Mi Mi ;
Kim, Kyung Jun ;
Lee, Jong Seok ;
Kim, Chang Ki ;
Cho, Sang Nae ;
Song, Sun Dae ;
Chang, Chulhun L. .
ANNALS OF LABORATORY MEDICINE, 2015, 35 (05) :494-499
[7]   INHA, A GENE ENCODING A TARGET FOR ISONIAZID AND ETHIONAMIDE IN MYCOBACTERIUM-TUBERCULOSIS [J].
BANERJEE, A ;
DUBNAU, E ;
QUEMARD, A ;
BALASUBRAMANIAN, V ;
UM, KS ;
WILSON, T ;
COLLINS, D ;
DELISLE, G ;
JACOBS, WR .
SCIENCE, 1994, 263 (5144) :227-230
[8]   Rapid Molecular Detection of Tuberculosis and Rifampin Resistance [J].
Boehme, Catharina C. ;
Nabeta, Pamela ;
Hillemann, Doris ;
Nicol, Mark P. ;
Shenai, Shubhada ;
Krapp, Fiorella ;
Allen, Jenny ;
Tahirli, Rasim ;
Blakemore, Robert ;
Rustomjee, Roxana ;
Milovic, Ana ;
Jones, Martin ;
O'Brien, Sean M. ;
Persing, David H. ;
Ruesch-Gerdes, Sabine ;
Gotuzzo, Eduardo ;
Rodrigues, Camilla ;
Alland, David ;
Perkins, Mark D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (11) :1005-1015
[9]   Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong [J].
Chan, Raphael C. Y. ;
Hui, Mamie ;
Chan, Edward W. C. ;
Au, T. K. ;
Chin, Miu. L. ;
Yip, Chun K. ;
AuYeang, Carrie K. W. ;
Yeung, Christina Y. L. ;
Kam, Kai M. ;
Yip, Peter C. W. ;
Cheng, Augustine E. B. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (05) :866-873
[10]  
Department of Disease Control Ministry of Public Health Bangkok Thailand, 2001, THAIL 2008 NAT MDR T